(Q46552861)

23 December 2017

title

Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status (English)

1 reference

23 December 2017

1 reference

T Furuta

1

1 reference

23 December 2017

N Shirai

2

1 reference

23 December 2017

M Sugimoto

3

1 reference

23 December 2017

A Nakamura

4

1 reference

23 December 2017

K Okudaira

5

1 reference

23 December 2017

M Kajimura

6

1 reference

23 December 2017

A Hishida

7

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

23 December 2017

Alimentary Pharmacology & Therapeutics

published in

1 reference

23 December 2017

volume

22

1 reference

23 December 2017

page(s)

67-74

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02523.X

10.1111/J.1365-2036.2005.02523.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

release_hrvtr4sedjdvxp54thc737onhu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hrvtr4sedjdvxp54thc737onhu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15963082

1 reference

23 December 2017